INCANNEX HEALTHCARE

Inactive Instrument

Highlights Incannex Healthcare Australian S.E.

Equities

IHL

AU000000IHL8

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Incannex Healthcare Inc. Announces Patient Dosing Commencement in RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea	May. 30	CI
Incannex Healthcare Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	May. 15	CI
Incannex Complete Successful Pre-Ind Meeting with the Fda for Cannquit-O for Treatment of Opioid Use Disorder	May. 07	CI
Incannex Announces Positive Topline Results from Phase 2 Psi-GAD1 Clinical Trial of Psilocybin in Generalised Anxiety Disorder	Feb. 28	CI
Incannex Healthcare Completes Pre-Investigational New Drug Meeting on CannQuit-N With US FDA	Feb. 16	MT
Incannex Healthcare Inc. Completes Successful Pre-IND Meeting with the FDA for CannQuit-N	Feb. 16	CI
Incannex Healthcare Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Feb. 14	CI
Incannex Commences Dosing in Phase 2 Clinical Trial Assessing IHL-675A in Patients with Rheumatoid Arthritis	Jan. 24	CI
Incannex Completes Dosing and Therapy in Phase 2 ?Psigad? Clinical Trial Assessing Psilocybin-Assisted Psychotherapy for Generalized Anxiety Disorder	Jan. 18	CI
Incannex Healthcare Gets Institutional Review Board Approval For IHL-42X Drug Trial	Jan. 17	MT
Incannex Healthcare Inc. Receives IRB Approval for the Reposa Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea	Jan. 17	CI
Incannex Healthcare Ltd. Receives Ethics Board Endorsement for Psychedelic Assisted Therapy At Its First Clinic Based in Melbourne, Australia	Dec. 21	CI
Incannex Healthcare Inc Update on Ihl-42X Drug Candidate in Phase 2/3 Clinical Trial in Obstructive Sleep Apnea	Dec. 06	CI
Incannex Healthcare Inc. Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-30	CI
Incannex Healthcare Inc. Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-26	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer